{"gene":"P2RX5","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1996,"finding":"P2RX5 (P2X5) encodes an ATP-gated ion channel with two transmembrane segments and a large extracellular loop; expressed in Xenopus oocytes/HEK cells, it produces slowly desensitizing currents that do not respond to alpha,beta-methylene-ATP and are not blocked by suramin or PPADS.","method":"cDNA cloning, heterologous expression, electrophysiology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — original cloning with functional characterization by patch-clamp in heterologous expression system","pmids":["8786426"],"is_preprint":false},{"year":1998,"finding":"P2X1 and P2X5 subunits co-assemble to form a novel heteromeric ATP-gated ion channel with distinct biphasic kinetics (fast desensitizing peak + sustained plateau) and a higher EC50 for alpha,beta-methylene-ATP than homomeric P2X1; co-immunoprecipitation of epitope-tagged subunits provided biochemical proof of heteromeric assembly.","method":"Heterologous co-expression in HEK293 cells, electrophysiology, co-immunoprecipitation","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — functional and biochemical evidence in a single study, replicated by subsequent papers","pmids":["9855626"],"is_preprint":false},{"year":1999,"finding":"P2X1 and P2X5 subunits form heteromeric channels with the pharmacology of P2X1 (sensitive to alpha,beta-methylene-ATP and TNP-ATP) but the slow-desensitization kinetics of P2X5; direct physical co-assembly was demonstrated by reciprocal subunit-specific co-purifications of epitope-tagged proteins in HEK-293A cells.","method":"Xenopus oocyte expression, electrophysiology, reciprocal co-purification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-purification plus functional characterization; independent replication of P2X1/5 heteromer","pmids":["10336430"],"is_preprint":false},{"year":1999,"finding":"P2X5 pharmacological properties characterised in more detail: plateau currents potentiated by low PPADS concentrations and raised extracellular Ca2+; agonist rank order and antagonist profile distinct from P2X1 homomers.","method":"Heterologous expression in HEK293, voltage-clamp electrophysiology","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro electrophysiology, single lab","pmids":["10496954"],"is_preprint":false},{"year":1999,"finding":"P2X5 immunoreactivity is localized to the proliferating and differentiating cell layers (spinous and granular layers) of stratified squamous epithelia and growing hair follicles, suggesting a role in epithelial cell turnover.","method":"Immunohistochemistry on rat stratified squamous epithelial tissues","journal":"Cell and tissue research","confidence":"Medium","confidence_rationale":"Tier 3 — immunolocalization without functional follow-up, but consistent across multiple tissue types","pmids":["10370147"],"is_preprint":false},{"year":2002,"finding":"P2RX5 is expressed on skeletal muscle satellite cells; ATP activation of P2X5 receptors on satellite cells inhibits proliferation, stimulates myogenic differentiation markers (myogenin, p21, myosin heavy chain), accelerates myotube formation, and rapidly increases p38 MAPK phosphorylation; p38 inhibition blocks ATP's effect on cell number.","method":"Primary rat satellite cell culture, immunocytochemistry, RT-PCR, electrophysiology, Western blot, pharmacological inhibition of p38","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single study establishing P2X5-dependent pathway from receptor activation to differentiation outcome","pmids":["12135987"],"is_preprint":false},{"year":2002,"finding":"Rat P2X5 homomeric receptor is sensitized by extracellular Ca2+; replacing Ca2+ with Ba2+ or Mg2+ prevents Ca2+-dependent rundown; Zn2+ first potentiates then inhibits ATP responses; reducing extracellular pH decreases agonist potency and efficacy; antagonist potency order: PPADS > TNP-ATP > suramin > RB-2 > Ip5I.","method":"Voltage-clamp in Xenopus oocytes expressing recombinant rat P2X5","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 — systematic in vitro electrophysiology, single lab","pmids":["12237343"],"is_preprint":false},{"year":2003,"finding":"Full-length human P2X5 (incorporating exon 10) forms functional ATP-gated channels; ATP (EC50 ~4 µM) evokes inward currents with slow desensitization; channel is permeable to Ca2+ (PCa/PNa=1.5), NMDG, and Cl-; inhibited by suramin, PPADS, and Brilliant Blue G; cells rapidly accumulate YO-PRO-1 dye indicating large-pore properties.","method":"Patch-clamp and fluorescence imaging of HEK293 cells expressing full-length human P2X5","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 — comprehensive biophysical and pharmacological characterization with multiple methods","pmids":["12761352"],"is_preprint":false},{"year":2005,"finding":"A frameshift polymorphism in the P2X5 gene creates the minor histocompatibility antigen LRH-1 presented by HLA-B7; differential protein expression (donor homozygous for frameshift → no protein) between donor and recipient generates an allogeneic CD8+ CTL response; LRH-1-specific CTL emergence correlates with CML remission after donor lymphocyte infusion.","method":"Genetic linkage analysis, tetramer analysis of CD8+ T cells, functional CTL assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic identification of polymorphism plus immunological functional validation in patient material","pmids":["16322791"],"is_preprint":false},{"year":2006,"finding":"The transmembrane domain 2 (TM2) of P2X5 is essential for homotrimerization; the C-terminal truncation caused by exon 10 skipping leaves a TM2 too short to span the membrane, causing subunit aggregation; mutagenesis identified Asp355 in TM2 as required for correct homotrimerization in a side-chain-specific manner.","method":"Systematic TM2 mutagenesis, biochemical trimerization assays, heterologous expression in Xenopus oocytes/HEK cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis combined with biochemical assembly assays","pmids":["17001079"],"is_preprint":false},{"year":2008,"finding":"In mouse cortical astrocytes, the functional P2X receptor mediating ATP-evoked currents comprises P2X1 and P2X5 subunits; this heteromeric channel shows high ATP sensitivity (EC50 ~40 nM), biphasic kinetics, PPADS sensitivity, and ivermectin insensitivity, consistent with recombinant P2X1/5 heteromers.","method":"Whole-cell voltage clamp on acutely isolated cortical astrocytes from transgenic GFAP-EGFP mice, quantitative RT-PCR","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — native cell electrophysiology combined with molecular expression profiling, consistent with prior heterologous data","pmids":["18495881"],"is_preprint":false},{"year":2010,"finding":"A SNP at the 3' splice site of exon 10 of human P2X5 determines whether exon 10 is included; the exon-10-deleted isoform is retained in the cytoplasm and is non-functional (no ATP-evoked currents or Ca2+ signals); the full-length isoform is expressed at the cell surface and is functional; most non-African humans are homozygous for the non-functional G allele.","method":"Genotyping of human DNA, immunostaining of stably co-expressing cell lines, electrophysiology and FLIPR calcium imaging","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods establishing genotype-phenotype link with functional consequence","pmids":["20223879"],"is_preprint":false},{"year":2012,"finding":"P2X5 subunits associate with P2X1, P2X2, and P2X4 subunits; P2X2/P2X5 heteromeric receptors form with alternate stoichiometries, are present at the plasma membrane, and display P2X7-like properties including pore dilatation, membrane blebbing, and phosphatidylserine exposure; P2X2 and P2X5 colocalize and physically interact in specific neuronal populations in mouse.","method":"BRET, bifunctional fluorescence complementation, co-immunoprecipitation, in vivo colocalization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — multiple biochemical and biophysical methods establishing novel heteromeric assembly and its functional consequences","pmids":["22442090"],"is_preprint":false},{"year":2014,"finding":"P2RX5 protein is a cell-surface marker selectively expressed in classical brown and beige adipocytes in mice and humans, with little or no expression in white adipocytes; identified by in silico, in vitro, and in vivo methods.","method":"In silico analysis, in vitro adipocyte characterization, in vivo adipose tissue profiling, immunostaining","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple convergent methods establishing cell-type-specific surface localization; functional consequence not directly tested for P2RX5","pmids":["25080478"],"is_preprint":false},{"year":2017,"finding":"P2X5 is required for ATP-mediated inflammasome activation and IL-1β production in osteoclasts; P2X5-deficient osteoclasts show hyper-multinucleation and impaired inflammatory bone loss in vivo; exogenous IL-1β rescues P2X5-deficient osteoclast maturation in vitro.","method":"P2rx5 knockout mice, in vitro osteoclast differentiation assays, IL-1β rescue experiments, in vivo inflammatory bone loss model","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — KO with specific cellular and in vivo phenotype plus mechanistic rescue experiment","pmids":["28298636"],"is_preprint":false},{"year":2018,"finding":"P2X5 deficiency reduces alveolar bone loss in a murine ligature-induced periodontitis model and decreases gingival expression of IL-1β, IL-6, IL-17a, and TNFSF11, placing P2X5 upstream of inflammatory cytokine production in periodontitis-associated bone destruction.","method":"P2rx5−/− mice, ligature-induced periodontitis model, micro-CT bone analysis, gene expression analysis","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined in vivo phenotype and pathway placement, single study","pmids":["30103845"],"is_preprint":false}],"current_model":"P2RX5 encodes an ATP-gated trimeric cation channel (P2X5) that forms slowly-desensitizing homomeric channels when the full-length exon-10-containing isoform is expressed (most humans carry a splice-site SNP yielding a non-functional, cytoplasmic truncated isoform), and preferentially assembles into heteromeric channels with P2X1 (in neurons, spinal cord, and astrocytes) or P2X2 subunits with altered pharmacokinetics and P2X7-like properties; in skeletal muscle satellite cells, P2X5 activation by extracellular ATP inhibits proliferation and drives myogenic differentiation via p38 MAPK, and in osteoclasts P2X5 mediates ATP-induced inflammasome activation and IL-1β production required for inflammatory bone loss, while a frameshift polymorphism in human P2RX5 generates the minor histocompatibility antigen LRH-1 that can elicit graft-versus-leukemia CTL responses."},"narrative":{"teleology":[{"year":1996,"claim":"Cloning of P2RX5 established that it encodes a new member of the ATP-gated ion channel family with a distinctive slowly desensitizing current and unique pharmacology, answering whether there were additional P2X subtypes with non-redundant properties.","evidence":"cDNA cloning from rat, heterologous expression in Xenopus oocytes and HEK cells, whole-cell electrophysiology","pmids":["8786426"],"confidence":"High","gaps":["No native tissue function demonstrated","Subunit stoichiometry and oligomeric state unknown","Human ortholog not yet characterized"]},{"year":1999,"claim":"Demonstration that P2X5 co-assembles with P2X1 into heteromeric channels with hybrid kinetics (fast P2X1 peak plus sustained P2X5 plateau) revealed that P2X subunit mixing diversifies purinergic signaling beyond what homomers provide.","evidence":"Co-expression in HEK293 and Xenopus oocytes, reciprocal co-purification of epitope-tagged subunits, electrophysiology","pmids":["9855626","10336430"],"confidence":"High","gaps":["Native tissue relevance of P2X1/5 heteromers not shown","Stoichiometry of heteromeric assembly unknown","Whether P2X5 forms heteromers with other P2X subunits untested"]},{"year":2002,"claim":"Identification of P2X5 on skeletal muscle satellite cells and demonstration that its activation suppresses proliferation and promotes myogenic differentiation via p38 MAPK provided the first physiological function for P2X5 homomeric signaling.","evidence":"Primary rat satellite cell culture with RT-PCR, electrophysiology, immunocytochemistry, Western blot for p38, and pharmacological p38 inhibition","pmids":["12135987"],"confidence":"High","gaps":["In vivo muscle regeneration phenotype not tested","Whether the effect requires homomeric or heteromeric P2X5 channels is unresolved","Downstream effectors beyond p38 not identified"]},{"year":2003,"claim":"Full biophysical characterization of human full-length P2X5 revealed Ca²⁺ permeability and large-pore (NMDG/YO-PRO-1 permeable) properties previously associated only with P2X7, expanding the functional repertoire of this channel.","evidence":"Patch-clamp and fluorescence dye uptake in HEK293 cells expressing full-length human P2X5","pmids":["12761352"],"confidence":"High","gaps":["Structural basis for pore dilation unknown","Physiological relevance of large-pore state not demonstrated in native cells"]},{"year":2005,"claim":"Discovery that a frameshift polymorphism in P2RX5 generates the minor histocompatibility antigen LRH-1, with CTL responses correlating with CML remission after donor lymphocyte infusion, linked P2RX5 genetic variation to graft-versus-leukemia immunity.","evidence":"Genetic linkage analysis, HLA-B7 tetramer staining of CD8⁺ T cells, functional CTL assays in patient samples","pmids":["16322791"],"confidence":"High","gaps":["Whether LRH-1-directed CTL activity is sufficient for remission versus a correlate is unclear","Broader HLA context not explored"]},{"year":2006,"claim":"Mutagenesis of TM2 showed that Asp355 and full-length TM2 are required for homotrimerization, explaining why the exon-10-skipped isoform fails to assemble and is non-functional.","evidence":"Systematic TM2 mutagenesis, biochemical trimerization assays in HEK cells and oocytes","pmids":["17001079"],"confidence":"High","gaps":["Structure of the assembled trimer not resolved at atomic level","Whether TM2 requirements differ for heteromeric assembly unknown"]},{"year":2008,"claim":"Electrophysiology of native cortical astrocytes demonstrated that the predominant P2X receptor is a P2X1/5 heteromer with nanomolar ATP sensitivity, establishing physiological relevance of this heteromeric combination in the CNS.","evidence":"Whole-cell patch clamp on acutely isolated astrocytes from GFAP-EGFP transgenic mice, qRT-PCR","pmids":["18495881"],"confidence":"High","gaps":["Functional consequence of astrocytic P2X1/5 activation for gliotransmission or calcium signaling not tested","Selective genetic ablation of P2X5 in astrocytes not performed"]},{"year":2010,"claim":"A splice-site SNP at exon 10 was shown to determine whether human P2X5 is functional (surface-expressed, full-length) or non-functional (cytoplasmic, truncated), with most non-African humans homozygous for the non-functional allele, resolving long-standing discrepancies in human P2X5 pharmacology.","evidence":"Human genotyping, immunostaining, electrophysiology, and FLIPR calcium imaging in stably expressing cell lines","pmids":["20223879"],"confidence":"High","gaps":["Phenotypic consequences of lacking functional homomeric P2X5 in the majority human population not characterized","Whether heteromeric channels containing the truncated isoform retain any function is unknown"]},{"year":2012,"claim":"Discovery that P2X5 also heteromerizes with P2X2 and that these channels exhibit P2X7-like pore dilation, membrane blebbing, and phosphatidylserine exposure broadened the functional impact of P2X5 heteromers beyond P2X1/5.","evidence":"BRET, bimolecular fluorescence complementation, co-immunoprecipitation, and colocalization in mouse neuronal tissue","pmids":["22442090"],"confidence":"High","gaps":["Stoichiometry of P2X2/5 heteromers not resolved","In vivo neuronal function of P2X2/5 channels not tested with subunit-specific knockouts"]},{"year":2017,"claim":"P2rx5 knockout mice revealed that P2X5 is required for ATP-induced inflammasome activation and IL-1β release in osteoclasts, and for inflammatory bone loss in vivo, establishing an immune-regulatory function distinct from ion conduction.","evidence":"P2rx5 knockout mice, in vitro osteoclast differentiation, IL-1β rescue, in vivo inflammatory bone loss model","pmids":["28298636"],"confidence":"High","gaps":["Mechanism by which P2X5 activates the inflammasome (direct ion flux versus signaling intermediate) not delineated","Whether the osteoclast phenotype is cell-autonomous not formally shown"]},{"year":2018,"claim":"Extension to periodontitis confirmed that P2X5 deficiency reduces alveolar bone loss and gingival inflammatory cytokine expression, placing P2X5 upstream of IL-1β, IL-6, IL-17a, and RANKL in oral inflammatory bone destruction.","evidence":"P2rx5−/− mice in ligature-induced periodontitis model, micro-CT, gene expression analysis","pmids":["30103845"],"confidence":"Medium","gaps":["Cell-type-specific contribution (osteoclast versus immune cell) not dissected","Single disease model without conditional knockout"]},{"year":null,"claim":"The structural basis for P2X5 homotrimer and heteromer gating, the molecular mechanism linking P2X5 to inflammasome assembly, the physiological consequences of widespread human P2X5 loss-of-function (exon 10 skipping), and the in vivo role of P2X5 in muscle regeneration remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of P2X5 homotrimer or any P2X5-containing heteromer","Mechanism of inflammasome coupling unknown","No conditional knockout studies to separate cell-autonomous functions in muscle, bone, or brain"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[7,11,13]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14,15]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,7]}],"complexes":["P2X5 homotrimer","P2X1/P2X5 heteromeric channel","P2X2/P2X5 heteromeric channel"],"partners":["P2RX1","P2RX2","P2RX4"],"other_free_text":[]},"mechanistic_narrative":"P2RX5 encodes the P2X5 subunit of ligand-gated ion channels that assemble as homotrimers or heterotrimers to mediate extracellular ATP signaling in diverse cell types including neurons, astrocytes, skeletal muscle satellite cells, osteoclasts, and adipocytes. The full-length homomeric P2X5 channel conducts slowly desensitizing cation currents with Ca²⁺ permeability and large-pore (YO-PRO-1-permeable) properties, and its assembly requires the second transmembrane domain encoded by exon 10—a common human splice-site SNP (G allele) causes exon 10 skipping, producing a cytoplasm-retained, non-functional isoform carried by most non-African populations [PMID:20223879, PMID:17001079, PMID:12761352]. P2X5 preferentially co-assembles with P2X1 to form heteromeric channels with nanomolar ATP sensitivity and biphasic kinetics in cortical astrocytes, and with P2X2 to produce channels exhibiting P2X7-like pore dilation and membrane blebbing in neurons [PMID:9855626, PMID:18495881, PMID:22442090]. Functionally, P2X5 activation on skeletal muscle satellite cells drives exit from proliferation and myogenic differentiation via p38 MAPK [PMID:12135987], while in osteoclasts P2X5 is required for ATP-induced inflammasome activation and IL-1β release that mediates inflammatory bone loss [PMID:28298636, PMID:30103845]."},"prefetch_data":{"uniprot":{"accession":"Q93086","full_name":"P2X purinoceptor 5","aliases":["ATP receptor","Purinergic receptor"],"length_aa":444,"mass_kda":49.3,"function":"ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:12761352). Unlike other P2RX receptors, the P2X5 receptor is also permeable to chloride (PubMed:12761352). May play a supporting role in the inflammatory response (By similarity) Non-functional","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q93086/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P2RX5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P2RX5","total_profiled":1310},"omim":[{"mim_id":"611741","title":"ACID-SENSING ION CHANNEL, SUBUNIT 3; ASIC3","url":"https://www.omim.org/entry/611741"},{"mim_id":"602836","title":"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 5; P2RX5","url":"https://www.omim.org/entry/602836"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":23.7},{"tissue":"lymphoid tissue","ntpm":73.8}],"url":"https://www.proteinatlas.org/search/P2RX5"},"hgnc":{"alias_symbol":["P2X5","LRH-1"],"prev_symbol":[]},"alphafold":{"accession":"Q93086","domains":[{"cath_id":"2.60.490.10","chopping":"64-113_190-332","consensus_level":"high","plddt":89.9916,"start":64,"end":332},{"cath_id":"-","chopping":"122-170","consensus_level":"high","plddt":90.8833,"start":122,"end":170}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93086","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q93086-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q93086-F1-predicted_aligned_error_v6.png","plddt_mean":81.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P2RX5","jax_strain_url":"https://www.jax.org/strain/search?query=P2RX5"},"sequence":{"accession":"Q93086","fasta_url":"https://rest.uniprot.org/uniprotkb/Q93086.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q93086/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q93086"}},"corpus_meta":[{"pmid":"11030332","id":"PMC_11030332","title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11030332","citation_count":1606,"is_preprint":false},{"pmid":"8786426","id":"PMC_8786426","title":"Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.","date":"1996","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/8786426","citation_count":768,"is_preprint":false},{"pmid":"15130581","id":"PMC_15130581","title":"LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.","date":"2004","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15130581","citation_count":348,"is_preprint":false},{"pmid":"15707893","id":"PMC_15707893","title":"Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15707893","citation_count":344,"is_preprint":false},{"pmid":"15327767","id":"PMC_15327767","title":"Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15327767","citation_count":251,"is_preprint":false},{"pmid":"15831456","id":"PMC_15831456","title":"Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15831456","citation_count":245,"is_preprint":false},{"pmid":"11927588","id":"PMC_11927588","title":"Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11927588","citation_count":204,"is_preprint":false},{"pmid":"15723037","id":"PMC_15723037","title":"Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP.","date":"2005","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15723037","citation_count":173,"is_preprint":false},{"pmid":"25080478","id":"PMC_25080478","title":"ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes.","date":"2014","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25080478","citation_count":162,"is_preprint":false},{"pmid":"20159957","id":"PMC_20159957","title":"GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20159957","citation_count":155,"is_preprint":false},{"pmid":"12865342","id":"PMC_12865342","title":"Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary.","date":"2003","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12865342","citation_count":148,"is_preprint":false},{"pmid":"18495881","id":"PMC_18495881","title":"P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18495881","citation_count":142,"is_preprint":false},{"pmid":"12820970","id":"PMC_12820970","title":"Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12820970","citation_count":139,"is_preprint":false},{"pmid":"17670946","id":"PMC_17670946","title":"LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17670946","citation_count":133,"is_preprint":false},{"pmid":"12972182","id":"PMC_12972182","title":"Expression of LRH-1 and SF-1 in the mouse ovary: localization in different cell types correlates with differing function.","date":"2003","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12972182","citation_count":130,"is_preprint":false},{"pmid":"12482977","id":"PMC_12482977","title":"LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12482977","citation_count":126,"is_preprint":false},{"pmid":"12837754","id":"PMC_12837754","title":"Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12837754","citation_count":125,"is_preprint":false},{"pmid":"11331284","id":"PMC_11331284","title":"The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11331284","citation_count":120,"is_preprint":false},{"pmid":"16322791","id":"PMC_16322791","title":"A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16322791","citation_count":117,"is_preprint":false},{"pmid":"23038264","id":"PMC_23038264","title":"Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23038264","citation_count":113,"is_preprint":false},{"pmid":"9855626","id":"PMC_9855626","title":"Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel.","date":"1998","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9855626","citation_count":112,"is_preprint":false},{"pmid":"12761352","id":"PMC_12761352","title":"Pharmacological and biophysical properties of the human P2X5 receptor.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12761352","citation_count":111,"is_preprint":false},{"pmid":"16923850","id":"PMC_16923850","title":"The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16923850","citation_count":111,"is_preprint":false},{"pmid":"12135987","id":"PMC_12135987","title":"ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12135987","citation_count":105,"is_preprint":false},{"pmid":"21949357","id":"PMC_21949357","title":"Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21949357","citation_count":97,"is_preprint":false},{"pmid":"10370147","id":"PMC_10370147","title":"Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia.","date":"1999","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/10370147","citation_count":94,"is_preprint":false},{"pmid":"22772466","id":"PMC_22772466","title":"LRH-1-dependent glucose sensing determines intermediary metabolism in liver.","date":"2012","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/22772466","citation_count":94,"is_preprint":false},{"pmid":"14736734","id":"PMC_14736734","title":"Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression.","date":"2004","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14736734","citation_count":90,"is_preprint":false},{"pmid":"20133449","id":"PMC_20133449","title":"PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20133449","citation_count":85,"is_preprint":false},{"pmid":"19015525","id":"PMC_19015525","title":"The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19015525","citation_count":82,"is_preprint":false},{"pmid":"15121760","id":"PMC_15121760","title":"The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter.","date":"2004","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/15121760","citation_count":79,"is_preprint":false},{"pmid":"23667258","id":"PMC_23667258","title":"Structure-based discovery of antagonists of nuclear receptor LRH-1.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23667258","citation_count":79,"is_preprint":false},{"pmid":"21852532","id":"PMC_21852532","title":"LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function.","date":"2011","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/21852532","citation_count":79,"is_preprint":false},{"pmid":"20817789","id":"PMC_20817789","title":"The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.","date":"2010","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20817789","citation_count":78,"is_preprint":false},{"pmid":"14766742","id":"PMC_14766742","title":"The role of alpha1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14766742","citation_count":76,"is_preprint":false},{"pmid":"10336430","id":"PMC_10336430","title":"Functional and biochemical evidence for heteromeric ATP-gated channels composed of P2X1 and P2X5 subunits.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10336430","citation_count":75,"is_preprint":false},{"pmid":"16439367","id":"PMC_16439367","title":"Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16439367","citation_count":75,"is_preprint":false},{"pmid":"20483916","id":"PMC_20483916","title":"Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20483916","citation_count":75,"is_preprint":false},{"pmid":"15923626","id":"PMC_15923626","title":"SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15923626","citation_count":72,"is_preprint":false},{"pmid":"21194563","id":"PMC_21194563","title":"Emerging actions of the nuclear receptor LRH-1 in the gut.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21194563","citation_count":66,"is_preprint":false},{"pmid":"25176150","id":"PMC_25176150","title":"SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25176150","citation_count":65,"is_preprint":false},{"pmid":"28094767","id":"PMC_28094767","title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/28094767","citation_count":64,"is_preprint":false},{"pmid":"30305617","id":"PMC_30305617","title":"LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30305617","citation_count":62,"is_preprint":false},{"pmid":"15026173","id":"PMC_15026173","title":"Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.","date":"2004","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/15026173","citation_count":61,"is_preprint":false},{"pmid":"21391689","id":"PMC_21391689","title":"Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).","date":"2011","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21391689","citation_count":61,"is_preprint":false},{"pmid":"22442090","id":"PMC_22442090","title":"P2X2 and P2X5 subunits define a new heteromeric receptor with P2X7-like properties.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22442090","citation_count":60,"is_preprint":false},{"pmid":"10496954","id":"PMC_10496954","title":"Properties of the novel ATP-gated ionotropic receptor composed of the P2X(1) and P2X(5) isoforms.","date":"1999","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10496954","citation_count":60,"is_preprint":false},{"pmid":"10762695","id":"PMC_10762695","title":"Evidence for P2X(3), P2X(4), P2X(5) but not for P2X(7) containing purinergic receptors in Müller cells of the rat retina.","date":"2000","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10762695","citation_count":59,"is_preprint":false},{"pmid":"24737860","id":"PMC_24737860","title":"Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution.","date":"2014","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/24737860","citation_count":57,"is_preprint":false},{"pmid":"25463843","id":"PMC_25463843","title":"Molecular basis for the regulation of the nuclear receptor LRH-1.","date":"2014","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25463843","citation_count":54,"is_preprint":false},{"pmid":"25951367","id":"PMC_25951367","title":"Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.","date":"2015","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25951367","citation_count":54,"is_preprint":false},{"pmid":"27298334","id":"PMC_27298334","title":"LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27298334","citation_count":54,"is_preprint":false},{"pmid":"22359603","id":"PMC_22359603","title":"The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22359603","citation_count":52,"is_preprint":false},{"pmid":"21273442","id":"PMC_21273442","title":"Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21273442","citation_count":52,"is_preprint":false},{"pmid":"28298636","id":"PMC_28298636","title":"The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28298636","citation_count":51,"is_preprint":false},{"pmid":"16289203","id":"PMC_16289203","title":"Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16289203","citation_count":51,"is_preprint":false},{"pmid":"20375098","id":"PMC_20375098","title":"Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20375098","citation_count":49,"is_preprint":false},{"pmid":"12237343","id":"PMC_12237343","title":"Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1).","date":"2002","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12237343","citation_count":48,"is_preprint":false},{"pmid":"29662071","id":"PMC_29662071","title":"LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29662071","citation_count":48,"is_preprint":false},{"pmid":"26400164","id":"PMC_26400164","title":"LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26400164","citation_count":48,"is_preprint":false},{"pmid":"10633863","id":"PMC_10633863","title":"Expression of two ATP-gated ion channels, P2X5 and P2X6, in developing chick skeletal muscle.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10633863","citation_count":47,"is_preprint":false},{"pmid":"25873311","id":"PMC_25873311","title":"LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARγ ligand synthesis.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25873311","citation_count":47,"is_preprint":false},{"pmid":"17001079","id":"PMC_17001079","title":"P2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17001079","citation_count":47,"is_preprint":false},{"pmid":"27983934","id":"PMC_27983934","title":"MicroRNA-219-5p Represses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Targeting the LRH-1/Wnt/β-Catenin Signaling Pathway.","date":"2016","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/27983934","citation_count":46,"is_preprint":false},{"pmid":"11549755","id":"PMC_11549755","title":"Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11549755","citation_count":45,"is_preprint":false},{"pmid":"29515023","id":"PMC_29515023","title":"LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29515023","citation_count":44,"is_preprint":false},{"pmid":"29378329","id":"PMC_29378329","title":"miR-1275 controls granulosa cell apoptosis and estradiol synthesis by impairing LRH-1/CYP19A1 axis.","date":"2018","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/29378329","citation_count":44,"is_preprint":false},{"pmid":"11389176","id":"PMC_11389176","title":"Genomic structure, developmental distribution and functional properties of the chicken P2X(5) receptor.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11389176","citation_count":44,"is_preprint":false},{"pmid":"20943815","id":"PMC_20943815","title":"Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA.","date":"2010","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20943815","citation_count":44,"is_preprint":false},{"pmid":"26320367","id":"PMC_26320367","title":"Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.","date":"2015","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/26320367","citation_count":44,"is_preprint":false},{"pmid":"39393353","id":"PMC_39393353","title":"Hepatic FXR-FGF4 is required for bile acid homeostasis via an FGFR4-LRH-1 signal node under cholestatic stress.","date":"2024","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39393353","citation_count":43,"is_preprint":false},{"pmid":"16427184","id":"PMC_16427184","title":"Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis.","date":"2006","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/16427184","citation_count":43,"is_preprint":false},{"pmid":"15551155","id":"PMC_15551155","title":"The distribution of P2X5 purinergic receptors in the enteric nervous system of mouse.","date":"2004","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15551155","citation_count":42,"is_preprint":false},{"pmid":"19074734","id":"PMC_19074734","title":"Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19074734","citation_count":40,"is_preprint":false},{"pmid":"16168958","id":"PMC_16168958","title":"Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16168958","citation_count":40,"is_preprint":false},{"pmid":"29438990","id":"PMC_29438990","title":"Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29438990","citation_count":39,"is_preprint":false},{"pmid":"19389484","id":"PMC_19389484","title":"Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1).","date":"2009","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19389484","citation_count":39,"is_preprint":false},{"pmid":"26653140","id":"PMC_26653140","title":"A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26653140","citation_count":38,"is_preprint":false},{"pmid":"14728801","id":"PMC_14728801","title":"LRH-1/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication.","date":"2003","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/14728801","citation_count":38,"is_preprint":false},{"pmid":"24520076","id":"PMC_24520076","title":"LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24520076","citation_count":37,"is_preprint":false},{"pmid":"18773945","id":"PMC_18773945","title":"Expression of P2X5 receptors in the mouse CNS.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18773945","citation_count":37,"is_preprint":false},{"pmid":"22296850","id":"PMC_22296850","title":"Genome-wide analysis of hepatic LRH-1 reveals a promoter binding preference and suggests a role in regulating genes of lipid metabolism in concert with FXR.","date":"2012","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/22296850","citation_count":36,"is_preprint":false},{"pmid":"24498423","id":"PMC_24498423","title":"Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24498423","citation_count":36,"is_preprint":false},{"pmid":"17204240","id":"PMC_17204240","title":"Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17204240","citation_count":36,"is_preprint":false},{"pmid":"18410452","id":"PMC_18410452","title":"Expression of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated lysis.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/18410452","citation_count":34,"is_preprint":false},{"pmid":"33862147","id":"PMC_33862147","title":"Emerging functions of the nuclear receptor LRH-1 in liver physiology and pathology.","date":"2021","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/33862147","citation_count":34,"is_preprint":false},{"pmid":"29128635","id":"PMC_29128635","title":"MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29128635","citation_count":32,"is_preprint":false},{"pmid":"20223879","id":"PMC_20223879","title":"Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoform.","date":"2010","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20223879","citation_count":32,"is_preprint":false},{"pmid":"16893604","id":"PMC_16893604","title":"LRH-1/NR5A2 cooperates with GATA factors to regulate inhibin alpha-subunit promoter activity.","date":"2006","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16893604","citation_count":30,"is_preprint":false},{"pmid":"23504956","id":"PMC_23504956","title":"Nuclear receptor LRH-1 induces the reproductive neuropeptide kisspeptin in the hypothalamus.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23504956","citation_count":29,"is_preprint":false},{"pmid":"31461657","id":"PMC_31461657","title":"The Ovulatory Signal Precipitates LRH-1 Transcriptional Switching Mediated by Differential Chromatin Accessibility.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31461657","citation_count":29,"is_preprint":false},{"pmid":"21536586","id":"PMC_21536586","title":"The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21536586","citation_count":29,"is_preprint":false},{"pmid":"34310734","id":"PMC_34310734","title":"NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34310734","citation_count":28,"is_preprint":false},{"pmid":"30122988","id":"PMC_30122988","title":"LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21.","date":"2018","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/30122988","citation_count":28,"is_preprint":false},{"pmid":"22100809","id":"PMC_22100809","title":"Regulation of miR-200c by nuclear receptors PPARα, LRH-1 and SHP.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22100809","citation_count":27,"is_preprint":false},{"pmid":"16765918","id":"PMC_16765918","title":"P2X5 receptors are expressed on neurons containing arginine vasopressin and nitric oxide synthase in the rat hypothalamus.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16765918","citation_count":27,"is_preprint":false},{"pmid":"32433991","id":"PMC_32433991","title":"Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and Function.","date":"2020","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/32433991","citation_count":27,"is_preprint":false},{"pmid":"20937355","id":"PMC_20937355","title":"LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells.","date":"2010","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20937355","citation_count":27,"is_preprint":false},{"pmid":"27049310","id":"PMC_27049310","title":"MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27049310","citation_count":26,"is_preprint":false},{"pmid":"30103845","id":"PMC_30103845","title":"The purinergic receptor P2X5 contributes to bone loss in experimental periodontitis.","date":"2018","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/30103845","citation_count":25,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47289,"output_tokens":3725,"usd":0.098871},"stage2":{"model":"claude-opus-4-6","input_tokens":7180,"output_tokens":3012,"usd":0.1668},"total_usd":0.265671,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"P2RX5 (P2X5) encodes an ATP-gated ion channel with two transmembrane segments and a large extracellular loop; expressed in Xenopus oocytes/HEK cells, it produces slowly desensitizing currents that do not respond to alpha,beta-methylene-ATP and are not blocked by suramin or PPADS.\",\n      \"method\": \"cDNA cloning, heterologous expression, electrophysiology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning with functional characterization by patch-clamp in heterologous expression system\",\n      \"pmids\": [\"8786426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"P2X1 and P2X5 subunits co-assemble to form a novel heteromeric ATP-gated ion channel with distinct biphasic kinetics (fast desensitizing peak + sustained plateau) and a higher EC50 for alpha,beta-methylene-ATP than homomeric P2X1; co-immunoprecipitation of epitope-tagged subunits provided biochemical proof of heteromeric assembly.\",\n      \"method\": \"Heterologous co-expression in HEK293 cells, electrophysiology, co-immunoprecipitation\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional and biochemical evidence in a single study, replicated by subsequent papers\",\n      \"pmids\": [\"9855626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"P2X1 and P2X5 subunits form heteromeric channels with the pharmacology of P2X1 (sensitive to alpha,beta-methylene-ATP and TNP-ATP) but the slow-desensitization kinetics of P2X5; direct physical co-assembly was demonstrated by reciprocal subunit-specific co-purifications of epitope-tagged proteins in HEK-293A cells.\",\n      \"method\": \"Xenopus oocyte expression, electrophysiology, reciprocal co-purification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-purification plus functional characterization; independent replication of P2X1/5 heteromer\",\n      \"pmids\": [\"10336430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"P2X5 pharmacological properties characterised in more detail: plateau currents potentiated by low PPADS concentrations and raised extracellular Ca2+; agonist rank order and antagonist profile distinct from P2X1 homomers.\",\n      \"method\": \"Heterologous expression in HEK293, voltage-clamp electrophysiology\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology, single lab\",\n      \"pmids\": [\"10496954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"P2X5 immunoreactivity is localized to the proliferating and differentiating cell layers (spinous and granular layers) of stratified squamous epithelia and growing hair follicles, suggesting a role in epithelial cell turnover.\",\n      \"method\": \"Immunohistochemistry on rat stratified squamous epithelial tissues\",\n      \"journal\": \"Cell and tissue research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — immunolocalization without functional follow-up, but consistent across multiple tissue types\",\n      \"pmids\": [\"10370147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"P2RX5 is expressed on skeletal muscle satellite cells; ATP activation of P2X5 receptors on satellite cells inhibits proliferation, stimulates myogenic differentiation markers (myogenin, p21, myosin heavy chain), accelerates myotube formation, and rapidly increases p38 MAPK phosphorylation; p38 inhibition blocks ATP's effect on cell number.\",\n      \"method\": \"Primary rat satellite cell culture, immunocytochemistry, RT-PCR, electrophysiology, Western blot, pharmacological inhibition of p38\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single study establishing P2X5-dependent pathway from receptor activation to differentiation outcome\",\n      \"pmids\": [\"12135987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Rat P2X5 homomeric receptor is sensitized by extracellular Ca2+; replacing Ca2+ with Ba2+ or Mg2+ prevents Ca2+-dependent rundown; Zn2+ first potentiates then inhibits ATP responses; reducing extracellular pH decreases agonist potency and efficacy; antagonist potency order: PPADS > TNP-ATP > suramin > RB-2 > Ip5I.\",\n      \"method\": \"Voltage-clamp in Xenopus oocytes expressing recombinant rat P2X5\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — systematic in vitro electrophysiology, single lab\",\n      \"pmids\": [\"12237343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Full-length human P2X5 (incorporating exon 10) forms functional ATP-gated channels; ATP (EC50 ~4 µM) evokes inward currents with slow desensitization; channel is permeable to Ca2+ (PCa/PNa=1.5), NMDG, and Cl-; inhibited by suramin, PPADS, and Brilliant Blue G; cells rapidly accumulate YO-PRO-1 dye indicating large-pore properties.\",\n      \"method\": \"Patch-clamp and fluorescence imaging of HEK293 cells expressing full-length human P2X5\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive biophysical and pharmacological characterization with multiple methods\",\n      \"pmids\": [\"12761352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A frameshift polymorphism in the P2X5 gene creates the minor histocompatibility antigen LRH-1 presented by HLA-B7; differential protein expression (donor homozygous for frameshift → no protein) between donor and recipient generates an allogeneic CD8+ CTL response; LRH-1-specific CTL emergence correlates with CML remission after donor lymphocyte infusion.\",\n      \"method\": \"Genetic linkage analysis, tetramer analysis of CD8+ T cells, functional CTL assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic identification of polymorphism plus immunological functional validation in patient material\",\n      \"pmids\": [\"16322791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The transmembrane domain 2 (TM2) of P2X5 is essential for homotrimerization; the C-terminal truncation caused by exon 10 skipping leaves a TM2 too short to span the membrane, causing subunit aggregation; mutagenesis identified Asp355 in TM2 as required for correct homotrimerization in a side-chain-specific manner.\",\n      \"method\": \"Systematic TM2 mutagenesis, biochemical trimerization assays, heterologous expression in Xenopus oocytes/HEK cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis combined with biochemical assembly assays\",\n      \"pmids\": [\"17001079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In mouse cortical astrocytes, the functional P2X receptor mediating ATP-evoked currents comprises P2X1 and P2X5 subunits; this heteromeric channel shows high ATP sensitivity (EC50 ~40 nM), biphasic kinetics, PPADS sensitivity, and ivermectin insensitivity, consistent with recombinant P2X1/5 heteromers.\",\n      \"method\": \"Whole-cell voltage clamp on acutely isolated cortical astrocytes from transgenic GFAP-EGFP mice, quantitative RT-PCR\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — native cell electrophysiology combined with molecular expression profiling, consistent with prior heterologous data\",\n      \"pmids\": [\"18495881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A SNP at the 3' splice site of exon 10 of human P2X5 determines whether exon 10 is included; the exon-10-deleted isoform is retained in the cytoplasm and is non-functional (no ATP-evoked currents or Ca2+ signals); the full-length isoform is expressed at the cell surface and is functional; most non-African humans are homozygous for the non-functional G allele.\",\n      \"method\": \"Genotyping of human DNA, immunostaining of stably co-expressing cell lines, electrophysiology and FLIPR calcium imaging\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods establishing genotype-phenotype link with functional consequence\",\n      \"pmids\": [\"20223879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2X5 subunits associate with P2X1, P2X2, and P2X4 subunits; P2X2/P2X5 heteromeric receptors form with alternate stoichiometries, are present at the plasma membrane, and display P2X7-like properties including pore dilatation, membrane blebbing, and phosphatidylserine exposure; P2X2 and P2X5 colocalize and physically interact in specific neuronal populations in mouse.\",\n      \"method\": \"BRET, bifunctional fluorescence complementation, co-immunoprecipitation, in vivo colocalization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple biochemical and biophysical methods establishing novel heteromeric assembly and its functional consequences\",\n      \"pmids\": [\"22442090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"P2RX5 protein is a cell-surface marker selectively expressed in classical brown and beige adipocytes in mice and humans, with little or no expression in white adipocytes; identified by in silico, in vitro, and in vivo methods.\",\n      \"method\": \"In silico analysis, in vitro adipocyte characterization, in vivo adipose tissue profiling, immunostaining\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple convergent methods establishing cell-type-specific surface localization; functional consequence not directly tested for P2RX5\",\n      \"pmids\": [\"25080478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"P2X5 is required for ATP-mediated inflammasome activation and IL-1β production in osteoclasts; P2X5-deficient osteoclasts show hyper-multinucleation and impaired inflammatory bone loss in vivo; exogenous IL-1β rescues P2X5-deficient osteoclast maturation in vitro.\",\n      \"method\": \"P2rx5 knockout mice, in vitro osteoclast differentiation assays, IL-1β rescue experiments, in vivo inflammatory bone loss model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific cellular and in vivo phenotype plus mechanistic rescue experiment\",\n      \"pmids\": [\"28298636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P2X5 deficiency reduces alveolar bone loss in a murine ligature-induced periodontitis model and decreases gingival expression of IL-1β, IL-6, IL-17a, and TNFSF11, placing P2X5 upstream of inflammatory cytokine production in periodontitis-associated bone destruction.\",\n      \"method\": \"P2rx5−/− mice, ligature-induced periodontitis model, micro-CT bone analysis, gene expression analysis\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined in vivo phenotype and pathway placement, single study\",\n      \"pmids\": [\"30103845\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P2RX5 encodes an ATP-gated trimeric cation channel (P2X5) that forms slowly-desensitizing homomeric channels when the full-length exon-10-containing isoform is expressed (most humans carry a splice-site SNP yielding a non-functional, cytoplasmic truncated isoform), and preferentially assembles into heteromeric channels with P2X1 (in neurons, spinal cord, and astrocytes) or P2X2 subunits with altered pharmacokinetics and P2X7-like properties; in skeletal muscle satellite cells, P2X5 activation by extracellular ATP inhibits proliferation and drives myogenic differentiation via p38 MAPK, and in osteoclasts P2X5 mediates ATP-induced inflammasome activation and IL-1β production required for inflammatory bone loss, while a frameshift polymorphism in human P2RX5 generates the minor histocompatibility antigen LRH-1 that can elicit graft-versus-leukemia CTL responses.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"P2RX5 encodes the P2X5 subunit of ligand-gated ion channels that assemble as homotrimers or heterotrimers to mediate extracellular ATP signaling in diverse cell types including neurons, astrocytes, skeletal muscle satellite cells, osteoclasts, and adipocytes. The full-length homomeric P2X5 channel conducts slowly desensitizing cation currents with Ca²⁺ permeability and large-pore (YO-PRO-1-permeable) properties, and its assembly requires the second transmembrane domain encoded by exon 10—a common human splice-site SNP (G allele) causes exon 10 skipping, producing a cytoplasm-retained, non-functional isoform carried by most non-African populations [PMID:20223879, PMID:17001079, PMID:12761352]. P2X5 preferentially co-assembles with P2X1 to form heteromeric channels with nanomolar ATP sensitivity and biphasic kinetics in cortical astrocytes, and with P2X2 to produce channels exhibiting P2X7-like pore dilation and membrane blebbing in neurons [PMID:9855626, PMID:18495881, PMID:22442090]. Functionally, P2X5 activation on skeletal muscle satellite cells drives exit from proliferation and myogenic differentiation via p38 MAPK [PMID:12135987], while in osteoclasts P2X5 is required for ATP-induced inflammasome activation and IL-1β release that mediates inflammatory bone loss [PMID:28298636, PMID:30103845].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Cloning of P2RX5 established that it encodes a new member of the ATP-gated ion channel family with a distinctive slowly desensitizing current and unique pharmacology, answering whether there were additional P2X subtypes with non-redundant properties.\",\n      \"evidence\": \"cDNA cloning from rat, heterologous expression in Xenopus oocytes and HEK cells, whole-cell electrophysiology\",\n      \"pmids\": [\"8786426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No native tissue function demonstrated\", \"Subunit stoichiometry and oligomeric state unknown\", \"Human ortholog not yet characterized\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that P2X5 co-assembles with P2X1 into heteromeric channels with hybrid kinetics (fast P2X1 peak plus sustained P2X5 plateau) revealed that P2X subunit mixing diversifies purinergic signaling beyond what homomers provide.\",\n      \"evidence\": \"Co-expression in HEK293 and Xenopus oocytes, reciprocal co-purification of epitope-tagged subunits, electrophysiology\",\n      \"pmids\": [\"9855626\", \"10336430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Native tissue relevance of P2X1/5 heteromers not shown\", \"Stoichiometry of heteromeric assembly unknown\", \"Whether P2X5 forms heteromers with other P2X subunits untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of P2X5 on skeletal muscle satellite cells and demonstration that its activation suppresses proliferation and promotes myogenic differentiation via p38 MAPK provided the first physiological function for P2X5 homomeric signaling.\",\n      \"evidence\": \"Primary rat satellite cell culture with RT-PCR, electrophysiology, immunocytochemistry, Western blot for p38, and pharmacological p38 inhibition\",\n      \"pmids\": [\"12135987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo muscle regeneration phenotype not tested\", \"Whether the effect requires homomeric or heteromeric P2X5 channels is unresolved\", \"Downstream effectors beyond p38 not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Full biophysical characterization of human full-length P2X5 revealed Ca²⁺ permeability and large-pore (NMDG/YO-PRO-1 permeable) properties previously associated only with P2X7, expanding the functional repertoire of this channel.\",\n      \"evidence\": \"Patch-clamp and fluorescence dye uptake in HEK293 cells expressing full-length human P2X5\",\n      \"pmids\": [\"12761352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for pore dilation unknown\", \"Physiological relevance of large-pore state not demonstrated in native cells\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that a frameshift polymorphism in P2RX5 generates the minor histocompatibility antigen LRH-1, with CTL responses correlating with CML remission after donor lymphocyte infusion, linked P2RX5 genetic variation to graft-versus-leukemia immunity.\",\n      \"evidence\": \"Genetic linkage analysis, HLA-B7 tetramer staining of CD8⁺ T cells, functional CTL assays in patient samples\",\n      \"pmids\": [\"16322791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LRH-1-directed CTL activity is sufficient for remission versus a correlate is unclear\", \"Broader HLA context not explored\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mutagenesis of TM2 showed that Asp355 and full-length TM2 are required for homotrimerization, explaining why the exon-10-skipped isoform fails to assemble and is non-functional.\",\n      \"evidence\": \"Systematic TM2 mutagenesis, biochemical trimerization assays in HEK cells and oocytes\",\n      \"pmids\": [\"17001079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the assembled trimer not resolved at atomic level\", \"Whether TM2 requirements differ for heteromeric assembly unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Electrophysiology of native cortical astrocytes demonstrated that the predominant P2X receptor is a P2X1/5 heteromer with nanomolar ATP sensitivity, establishing physiological relevance of this heteromeric combination in the CNS.\",\n      \"evidence\": \"Whole-cell patch clamp on acutely isolated astrocytes from GFAP-EGFP transgenic mice, qRT-PCR\",\n      \"pmids\": [\"18495881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of astrocytic P2X1/5 activation for gliotransmission or calcium signaling not tested\", \"Selective genetic ablation of P2X5 in astrocytes not performed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A splice-site SNP at exon 10 was shown to determine whether human P2X5 is functional (surface-expressed, full-length) or non-functional (cytoplasmic, truncated), with most non-African humans homozygous for the non-functional allele, resolving long-standing discrepancies in human P2X5 pharmacology.\",\n      \"evidence\": \"Human genotyping, immunostaining, electrophysiology, and FLIPR calcium imaging in stably expressing cell lines\",\n      \"pmids\": [\"20223879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phenotypic consequences of lacking functional homomeric P2X5 in the majority human population not characterized\", \"Whether heteromeric channels containing the truncated isoform retain any function is unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that P2X5 also heteromerizes with P2X2 and that these channels exhibit P2X7-like pore dilation, membrane blebbing, and phosphatidylserine exposure broadened the functional impact of P2X5 heteromers beyond P2X1/5.\",\n      \"evidence\": \"BRET, bimolecular fluorescence complementation, co-immunoprecipitation, and colocalization in mouse neuronal tissue\",\n      \"pmids\": [\"22442090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of P2X2/5 heteromers not resolved\", \"In vivo neuronal function of P2X2/5 channels not tested with subunit-specific knockouts\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"P2rx5 knockout mice revealed that P2X5 is required for ATP-induced inflammasome activation and IL-1β release in osteoclasts, and for inflammatory bone loss in vivo, establishing an immune-regulatory function distinct from ion conduction.\",\n      \"evidence\": \"P2rx5 knockout mice, in vitro osteoclast differentiation, IL-1β rescue, in vivo inflammatory bone loss model\",\n      \"pmids\": [\"28298636\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which P2X5 activates the inflammasome (direct ion flux versus signaling intermediate) not delineated\", \"Whether the osteoclast phenotype is cell-autonomous not formally shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extension to periodontitis confirmed that P2X5 deficiency reduces alveolar bone loss and gingival inflammatory cytokine expression, placing P2X5 upstream of IL-1β, IL-6, IL-17a, and RANKL in oral inflammatory bone destruction.\",\n      \"evidence\": \"P2rx5−/− mice in ligature-induced periodontitis model, micro-CT, gene expression analysis\",\n      \"pmids\": [\"30103845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific contribution (osteoclast versus immune cell) not dissected\", \"Single disease model without conditional knockout\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for P2X5 homotrimer and heteromer gating, the molecular mechanism linking P2X5 to inflammasome assembly, the physiological consequences of widespread human P2X5 loss-of-function (exon 10 skipping), and the in vivo role of P2X5 in muscle regeneration remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of P2X5 homotrimer or any P2X5-containing heteromer\", \"Mechanism of inflammasome coupling unknown\", \"No conditional knockout studies to separate cell-autonomous functions in muscle, bone, or brain\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 11, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14, 15]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"complexes\": [\n      \"P2X5 homotrimer\",\n      \"P2X1/P2X5 heteromeric channel\",\n      \"P2X2/P2X5 heteromeric channel\"\n    ],\n    \"partners\": [\n      \"P2RX1\",\n      \"P2RX2\",\n      \"P2RX4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}